M
27.35
0.26 (0.96%)
| Previous Close | 27.09 |
| Open | 27.10 |
| Volume | 1,135,950 |
| Avg. Volume (3M) | 372,231 |
| Market Cap | 1,193,950,592 |
| Price / Book | 3.87 |
| 52 Weeks Range | |
| Earnings Date | 12 May 2023 |
| Diluted EPS (TTM) | -2.30 |
| Total Debt/Equity (MRQ) | 18.32% |
| Current Ratio (MRQ) | 21.11 |
| Operating Cash Flow (TTM) | -139.78 M |
| Levered Free Cash Flow (TTM) | -102.40 M |
| Return on Assets (TTM) | -19.85% |
| Return on Equity (TTM) | -30.64% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | MoonLake Immunotherapeutics | Bullish | Bearish |
AIStockmoo Score
1.3
| Analyst Consensus | -1.5 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.25 |
|
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Mid Growth |
| % Held by Insiders | 15.34% |
| % Held by Institutions | 96.70% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 35.00 (Oppenheimer, 27.97%) | Buy |
| Median | 27.50 (0.55%) | |
| Low | 10.00 (Goldman Sachs, -63.44%) | Sell |
| Average | 24.00 (-12.25%) | |
| Total | 4 Buy, 1 Hold, 1 Sell | |
| Avg. Price @ Call | 17.33 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Oppenheimer | 24 Feb 2026 | 35.00 (27.97%) | Buy | 18.07 |
| BTIG | 23 Feb 2026 | 30.00 (9.69%) | Buy | 18.07 |
| 09 Feb 2026 | 24.00 (-12.25%) | Buy | 15.75 | |
| Needham | 23 Feb 2026 | 25.00 (-8.59%) | Buy | 18.07 |
| RBC Capital | 20 Feb 2026 | 12.00 (-56.12%) | Hold | 18.07 |
| HC Wainwright & Co. | 03 Feb 2026 | 32.00 (17.00%) | Buy | 15.37 |
| 09 Jan 2026 | 32.00 (17.00%) | Buy | 18.49 | |
| Goldman Sachs | 15 Jan 2026 | 10.00 (-63.44%) | Sell | 16.35 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |